Biochemical markers as a predictor for lymph-node involvement in patients with cervical-cancer of the uterus.

Kobayashi H, Fujishiro S, Terao T
International journal of oncology · 1994 · doi:10.3892/ijo.4.5.1053 · PMID:21567019
OA: closed
Full text JSON View on PubMed View at publisher
⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-25 · read from full text ⓘ

This study evaluated tumor-associated urokinase-type plasminogen activator (uPA) and granulocyte-derived elastase as predictors for lymph node involvement in patients with stage II cervical cancer. Researchers analyzed tissue samples from 29 individuals, finding that strong uPA staining was significantly associated with a higher rate of positive lymph nodes compared to weak staining. The investigation also noted intense inflammatory reactions at the tumor-stroma interface, where phagocytic cells secreted granulocyte elastase. Relevance to endometriosis: The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The present study was undertaken to assess the role of tumor associated urokinase-type plasminogen activator (uPA) and tumor infiltrating granulocyte-derived elastase as a positive and a negative predictor for lymph node involvement in patients with stage II cervical cancer of the uterus. uPA and uPA binding proteins (uPA receptors) were quantitated enzymologically and/or immunologically in cell membrane preparations obtained from cancer tissues. The cell membrane preparations express pro-uPA/uPA, uPA is bound to a specific type of surface receptors, of which more than 50% are saturated. Most of the receptor-bound uPA is enzymologically inactive pro-uPA. We have investigated the localization of pro-uPA/uPA and granulocyte elastase immunohistochemically and semiquantitated in formalin-fixed paraffin-embedded tissue sections in 13 patients with pelvic lymph node involvement and in 16 cases without lymph node involvement. Strong uPA staining was found in areas with invasive growth and degradation of surrounding normal tissue. A significant higher lymph node positive rate was observed in patients who had tumors with strong uPA staining than in those with weak staining (p<0.05). In contrast, phagocytic cells were found close to the tumor cells, and were located in aggregates or diffusely spread within tumor stroma surrounding the tumor nests. The inflammatory reaction seems to be most intense at the border between surrounding normal stromal cells and malignant epithelial cells. These cells produced and secreted granulocyte elastase.
Full text 4,097 characters · extracted from oa-doi-fallback · click to expand
Print ISSN: 1019-6439 Online ISSN: 1791-2423 International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease. International Journal of Oncology is an international journal devoted to oncology research and cancer treatment. Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery. Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine. Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology. International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis. Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology. Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition. Publishes open-access research on using epigenetics to advance understanding and treatment of human disease. An International Open Access Journal Devoted to General Medicine. Article - Authors: - Pages: 1053-1059|Published online on: May 1, 1994https://doi.org/10.3892/ijo.4.5.1053 - Expand metrics + The present study was undertaken to assess the role of tumor associated urokinase-type plasminogen activator (uPA) and tumor infiltrating granulocyte-derived elastase as a positive and a negative predictor for lymph node involvement in patients with stage II cervical cancer of the uterus. uPA and uPA binding proteins (uPA receptors) were quantitated enzymologically and/or immunologically in cell membrane preparations obtained from cancer tissues. The cell membrane preparations express pro-uPA/uPA, uPA is bound to a specific type of surface receptors, of which more than 50% are saturated. Most of the receptor-bound uPA is enzymologically inactive pro-uPA. We have investigated the localization of pro-uPA/uPA and granulocyte elastase immunohistochemically and semiquantitated in formalin-fixed paraffin-embedded tissue sections in 13 patients with pelvic lymph node involvement and in 16 cases without lymph node involvement. Strong uPA staining was found in areas with invasive growth and degradation of surrounding normal tissue. A significant higher lymph node positive rate was observed in patients who had tumors with strong uPA staining than in those with weak staining (p<0.05). In contrast, phagocytic cells were found close to the tumor cells, and were located in aggregates or diffusely spread within tumor stroma surrounding the tumor nests. The inflammatory reaction seems to be most intense at the border between surrounding normal stromal cells and malignant epithelial cells. These cells produced and secreted granulocyte elastase. Copy and paste a formatted citation Spandidos Publications style KOBAYASHI H, FUJISHIRO S and TERAO T: BIOCHEMICAL MARKERS AS A PREDICTOR FOR LYMPH-NODE INVOLVEMENT IN PATIENTS WITH CERVICAL-CANCER OF THE UTERUS. Int J Oncol 4: 1053-1059, 1994. APA KOBAYASHI, H., FUJISHIRO, S., & TERAO, T. (1994). BIOCHEMICAL MARKERS AS A PREDICTOR FOR LYMPH-NODE INVOLVEMENT IN PATIENTS WITH CERVICAL-CANCER OF THE UTERUS. International Journal of Oncology, 4, 1053-1059. https://doi.org/10.3892/ijo.4.5.1053 MLA KOBAYASHI, H., FUJISHIRO, S., TERAO, T."BIOCHEMICAL MARKERS AS A PREDICTOR FOR LYMPH-NODE INVOLVEMENT IN PATIENTS WITH CERVICAL-CANCER OF THE UTERUS". International Journal of Oncology 4.5 (1994): 1053-1059. Chicago KOBAYASHI, H., FUJISHIRO, S., TERAO, T."BIOCHEMICAL MARKERS AS A PREDICTOR FOR LYMPH-NODE INVOLVEMENT IN PATIENTS WITH CERVICAL-CANCER OF THE UTERUS". International Journal of Oncology 4, no. 5 (1994): 1053-1059. https://doi.org/10.3892/ijo.4.5.1053

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-30T09:23:35.175841+00:00
unpaywall
last seen: 2026-09-01T06:29:04.589233+00:00